Renal outcomes and all-cause death associated with sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL 3 Korea).
Eun Sil KohKyungdo HanYou-Seon NamEric T WittbrodtPeter FeniciMikhail Naum KosiborodHiddo J Lambers HeerspinkSoon-Jib YooHyuk-Sang KwonPublished in: Diabetes, obesity & metabolism (2020)
In this large nationwide study of Korean patients with T2D, initiation of SGLT2 inhibitors versus oGLDs was associated with lower risk of ESRD and all-cause death.